PubMed

Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity.

Freeburg EM, Goyeneche AA, Seidel EE, Telleria CM.

Cancer Cell Int. 2009 Feb 17;9:4.PMID: 19222856 [PubMed]Free PMC ArticleFree textRelated citations

Mifepristone abrogates repopulation of ovarian cancer cells in between courses of cisplatin treatment.

Freeburg EM, Goyeneche AA, Telleria CM.

Int J Oncol. 2009 Mar;34(3):743-55.PMID: 19212679 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

[Effects of mifepristone on the proliferation, apoptosis, and cis-platinum (DDP) sensitivity of chemo-resistant human ovarian cancer cells]

Wang G, Zheng WT, Xiao P, Li XJ, Lin TC, Li GY.

Ai Zheng. 2004 Apr;23(4):406-11. Chinese. PMID: 15087028 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Sustained suppression of Fas ligand expression in cisplatin-resistant human ovarian surface epithelial cancer cells.

Schneiderman D, Kim JM, Senterman M, Tsang BK.

Apoptosis. 1999 Aug;4(4):271-81.PMID: 14692397 [PubMed]Related citations

Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.

Zhang Y, Wang J, Xiang D, Wang D, Xin X.

Int J Oncol. 2009 Nov;35(5):1069-79.PMID: 19787261 [PubMed - indexed for MEDLINE]Related citations

Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells.

Montopoli M, Ragazzi E, Froldi G, Caparrotta L.

Cell Prolif. 2009 Apr;42(2):195-206. Epub 2009 Feb 18.PMID: 19236381 [PubMed - indexed for MEDLINE]Related citations

Induction of programmed cell death by inhibition of AKT with the alkylphosphocholine perifosine in in vitro models of platinum sensitive and resistant ovarian cancers.

Engel JB, Schönhals T, Häusler S, Krockenberger M, Schmidt M, Horn E, Köster F, Dietl J, Wischhusen J, Honig A.

Arch Gynecol Obstet. 2010 Apr 20. [Epub ahead of print]PMID: 20405296 [PubMed - as supplied by publisher]Related citations

Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway.

Arafa el-SA, Zhu Q, Barakat BM, Wani G, Zhao Q, El-Mahdy MA, Wani AA.

Cancer Res. 2009 Dec 1;69(23):8910-7. Epub 2009 Nov 10.PMID: 19903849 [PubMed - indexed for MEDLINE]Related citations

NSC109268 potentiates cisplatin-induced cell death in a p53-independent manner.

Shankar E, Basu C, Adkins B, Siede W, Basu A.

J Mol Signal. 2010 May 10;5:4.PMID: 20459745 [PubMed - in process]Free PMC ArticleFree textRelated citations

[Influence of mifepristone on DNA repair genes and cisplatin sensitivity in human ovarian cancer drug-resistance cells]

Liu GY, Qu QX, Mi RR, Qi J.

Zhonghua Fu Chan Ke Za Zhi. 2008 Feb;43(2):132-5. Chinese. PMID: 18683754 [PubMed - in process]Related citations

Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells.

Marverti G, Ligabue A, Paglietti G, Corona P, Piras S, Vitale G, Guerrieri D, Luciani R, Costi MP, Frassineti C, Moruzzi MS.

Eur J Pharmacol. 2009 Aug 1;615(1-3):17-26. Epub 2009 May 14.PMID: 19446547 [PubMed - indexed for MEDLINE]Related citations

Inhibition of human ovarian cancer cell lines by Devil's club Oplopanax horridus.

Tai J, Cheung S, Chan E, Hasman D.

J Ethnopharmacol. 2010 Feb 3;127(2):478-85. Epub 2009 Oct 14.PMID: 19835944 [PubMed - in process]Related citations

Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum-phosphato complexes towards human ovarian cancer cells.

Bose RN, Maurmann L, Mishur RJ, Yasui L, Gupta S, Grayburn WS, Hofstetter H, Salley T.

Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18314-9. Epub 2008 Nov 19. Erratum in: Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1292. Milton, Tara [corrected to Salley, Tara]. PMID: 19020081 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Synthetic isothiocyanate indole-3-ethyl isothiocyanate (homoITC) enhances sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to cisplatin.

Stehlik P, Paulikova H, Hunakova L.

Neoplasma. 2010;57(5):473-81.PMID: 20568902 [PubMed - in process]Related citations

Immune modulator CD70 as a potential cisplatin resistance predictive marker in ovarian cancer.

Aggarwal S, He T, Fitzhugh W, Rosenthal K, Feild B, Heidbrink J, Mesmer D, Ruben SM, Moore PA.

Gynecol Oncol. 2009 Dec;115(3):430-7. Epub 2009 Oct 2.PMID: 19800108 [PubMed - indexed for MEDLINE]Related citations

Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH3)2}2mu-{trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in ovarian cancer cell lines.

Tayyem H, Huq F, Yu JQ, Beale P, Fisher K.

ChemMedChem. 2008 Jan;3(1):145-51.PMID: 17963210 [PubMed - indexed for MEDLINE]Related citations

[Mifepristone modulates glucosylceramide synthase expression and reverse multidrug resistance in ovarian cancer cells]

Liu Y, Wang LL.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 Aug;28(9):1727-30. Chinese. PMID: 18819906 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Cisplatin cytotoxicity is increased by mifepristone in cervical carcinoma: an in vitro and in vivo study.

Jurado R, Lopez-Flores A, Alvarez A, García-López P.

Oncol Rep. 2009 Nov;22(5):1237-45.PMID: 19787245 [PubMed - indexed for MEDLINE]Related citations

BRCA1 Expression is an Important Biomarker for Chemosensitivity: Suppression of BRCA1 Increases the Apoptosis via Up-regulation of p53 and p21 During Cisplatin Treatment in Ovarian Cancer Cells.

Horiuchi A, Wang C, Kikuchi N, Osada R, Nikaido T, Konishi I.

Biomark Insights. 2007 Mar 2;1:49-59.PMID: 19690636 [PubMed - in process]Free PMC ArticleFree textRelated citations

MDR1 and MDR3 genes and drug resistance to cisplatin of ovarian cancer cells.

Ren L, Xiao L, Hu J.

J Huazhong Univ Sci Technolog Med Sci. 2007 Dec;27(6):721-4.PMID: 18231753 [PubMed - in process]Related citations